Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms.

Bhatara, V S; Magnus, R D; Paul, K L; Preskorn, S H

Bhatara, V S; Magnus, R D; Paul, K L; Preskorn, S H.

Affiliation

Bhatara VS; Child Psychiatry, University of South Dakota School of Medicine, Sioux Falls, USA.

Ann Pharmacother ; 32(4): 432-6, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9562139

Subject(s)

Cyclohexanols/adverse effects; Fluoxetine/adverse effects; Selective Serotonin Reuptake Inhibitors/adverse effects; Serotonin/physiology; Adult; Cyclohexanols/pharmacokinetics; Depressive Disorder/complications; Depressive Disorder/drug therapy; Drug Interactions; Female; Fluoxetine/pharmacokinetics; Humans; Panic Disorder/complications; Panic Disorder/drug therapy; Selective Serotonin Reuptake Inhibitors/pharmacokinetics; Venlafaxine Hydrochloride

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Serotonin / Fluoxetine / Selective Serotonin Reuptake Inhibitors / Cyclohexanols Limits: Adult / Female / Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links